SCIESCOPUSQ3
Immuno
MDPI, Switzerland
Immuno is an academic journal published by MDPI (Switzerland). Identifiers: eISSN 2673-5601. Indexed in SCIE, SCOPUS. Metrics: JIF 2.5, CiteScore 3.7, SJR 0.617, SNIP 0.53. Subject areas: IMMUNOLOGY. tlooto lists 337 papers from this journal.
CiteScore
3.70
Scopus citation metric
SJR
0.617
SCImago rank
SNIP
0.53
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- -
- eISSN
- 2673-5601
- Abbreviation
- IMMUNO-BASEL
- Publisher
- MDPI
- Country
- Switzerland
Web of Science categories
No Web of Science category data available.
Scopus ASJC categories
1301 Biochemistry2403 Immunology2701 Medicine (miscellaneous)
Papers in this journal
Recent papers
- Balancing Nutrition and Inflammation: The Role of a Healthy Diet in NLRP3 Inflammasome Activation
2026
- Characterization of Extracellular Vesicle-Enriched Populations in B-Cell Acute Lymphoblastic Leukemia from Peripheral Blood
2026
- Use of Thrombopoietin Receptor Agonists in Severe Aplastic Anemia During Pregnancy: A Case Report
2026
- Association of Treatment Status with Cytokine and sCTLA-4 Profiles in Rheumatoid Arthritis
2026
- Nanobiotechnology-Based Strategies for Targeting Neuroinflammation and Neural Tissue Engineering
2026
Most cited papers
- Host–Pathogen Interaction in Leishmaniasis: Immune Response and Vaccination Strategies
2022 · 46 citations
- The Immunomodulatory Effects of Statins on Macrophages
2022 · 41 citations
- Clostridium perfringens-Induced Necrotic Diseases: An Overview
2022 · 39 citations
- Long COVID (PASC) Is Maintained by a Self-Sustaining Pro-Inflammatory TLR4/RAGE-Loop of S100A8/A9 > TLR4/RAGE Signalling, Inducing Chronic Expression of IL-1b, IL-6 and TNFa: Anti-Inflammatory Ezrin Peptides as Potential Therapy
2022 · 37 citations
- Gut Microbiome as a Target of Intervention in Inflammatory Bowel Disease Pathogenesis and Therapy
2024 · 37 citations